ETON

Eton Pharmaceuticals, Inc.

3.61 USD
+0.05 (+1.40%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Eton Pharmaceuticals, Inc. stock is down -0.28% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 June’s closed higher than May.

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting from vasodilation in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age.